Piscataway, NJ (PRWEB) August 02, 2014
For the past five years, the New Jersey Center for Biomaterials under the auspices of the Armed Forces Institute of Regenerative Medicine (AFIRM) has led a consortium of academic research organizations in the development of advanced treatment options for our severely wounded warriors. AFIRM is a multi-institutional, inter¬disciplinary network working to develop new products and therapies to treat severe injuries suffered by US servicemen and women in the current wars. The AFIRM teams, working in research laboratories and clinics across the country, are advancing biological therapies (including adult stem cells and growth factors), tissue and biomaterials engineering, and advanced transplantation methods. These new treatments will enable the body to repair, replace, restore and regenerate damaged tissues and organs.
The 12th New Jersey Symposium on Biomaterials Science will focus several presentations on the regeneration of nerves and muscle resulting from catastrophic peripheral nerve injury and muscular tissue loss for Wounded Warriors. These types of injuries to the body’s soft tissue are leading sources of lifelong disability. Extreme trauma from combat wounds can cause nerve injuries that create gaps in the nerves leading to the muscles of the limbs. The success in this work for our Wounded Warriors is readily translatable to injuries suffered by the civilian population resulting from industrial and automobile accidents.
Registration for the 12th NJ Symposium on Biomaterials Science is available at http://www.njbiomaterials.org/biomaterials-symposia.htm.
The New Jersey Center for Biomaterials (NJCBM) was founded in 1997. Based at Rutgers, the State University of New Jersey, the center s
Copyright©2014 Vocus, Inc.
All rights reserved